Effect of all-trans retinoic acid on liver fibrosis induced by common bile duct ligation in rats

Abstract

The aim of this study was to investigate the effect and possible mechanism of all-trans retinoic acid (ATRA) on liver fibrosis induced by common bile duct ligation (CBDL) in rats. Fifty-three female Wistar rats were randomly divided into 5 groups: sham operation group (group J, 5 animals) and groups A, B, C and D (12 animals in each group). The rats in groups A, B, C and D were subjected to CBDL to induce liver fibrosis, while those in group J to sham operation. From the 3rd week the rats in groups B, C and D respectively received daily administration of ATRA via gastric tube at three different doses [0.1, 1.5 and 7.5 mg/kg body weight (BW)]. Animals were sacrificed at 6th week. Rats’ liver tissues were observed for pathologic changes under a light microscope. The protein levels of type I collagen (COL I), matrix metalloproteinase-2 (MMP2), MMP13 and tissue inhibitors of metalloproteinase-1 (TIMP-1) in liver tissues were determined by immunohistochemical techniques. The expression levels of TGF-β1 and CTGF mRNA in liver tissues were detected by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR). The results showed that loss of normal hepatic architecture and formation of obvious fibrosis were observed in group A, while ATRA treatment for 4 weeks notably alleviated the pathological changes of hepatocytes. The expression of COL I and TIMP-1 proteins in group A was increased, while decreased in ATRA-treated CBDL groups (P<0.05). ATRA (1.5 and 7.5 mg/kg BW) reduced the expression levels of COL I protein more greatly than that of 0.1 mg/kg BW (P<0.05). ATRA treatment increased the protein levels of MMP2 and MMP13. The expression levels of TGF-β1 and CTGF mRNA in group A were increased. In comparison with group A, the mRNA levels of TGF-β1 and CTGF in ATRA-treated CBDL groups were significantly decreased (P<0.05). It was concluded that ATRA could inhibit CBDL-induced liver fibrosis in rats by suppressing the expression of TGF-β1 and CTGF so as to diminish the inhibition of TIMP-1 on MMP2 and MMP13 and increase the activity of MMP2 and MMP13.

Keywords

liver fibrosis / all-trans retinoic acid / COL I / MMP2 / MMP13 / TIMP-1 / CTGF / TGF-β1

References

[1] FuY., DanZ. L., TangW. X., et al.. Effect of all-trans retinoic acid on expression of TGF-1, CTGF and Collal in chronic alcoholic liver disease in rats. Shijie Huaren Xiaohua Zazhi, 2006, 2: 179-183

[2] MathewJ., GeertsA., BurtA. D.. Pathobiology of hepatic stellate cells. Hepatogastroenterology, 1996, 43(7): 72-91

[3] FriedmanS. L.. Hepatic stellate cells. Prog Liver Dis, 1996, 14: 101-130

[4] ReevesH. L., FriedmanS. L.. Activation of hepatic stellate cells-a key issue in liver fibrosis. Front Biosci, 2002, 7: d808-d826

[5] SaremM., ZnaidakR., MacíasM., et al.. Hepatic stellate cells: its role in normal and pathological conditions. Gastroenterol Hepatol, 2006, 29(2): 93-101

[6] FriedmanS. L., WeiS., BlanerW. S.. Retinol release by activated rat hepatic lipocytes: regulation by Kupffer cell-conditioned medium and PDGF. Am J Physiol, 1993, 264(5Pt1): G947-G952

[7] YamaneM., TanakaY., MarumoF., et al.. Role of hepatic vitamin A and lipocyte distribution in experimental hepatic fibrosis. Liver, 1993, 13(5): 282-287

[8] DavisB. H., KramerR. T., DavidsonN. O.. Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J Clin Invest, 1990, 86(6): 2062-2070

[9] WeinerF. R., BlanerW. S., CzajaM. J., et al.. Ito cell expression of a nuclear retinoic acid receptor. Hepatology, 1992, 15(2): 336-342

[10] De LucaL. M.. Multiple mechanisms: the example of vitamin A. Basic Life Sci, 1993, 61: 17-25

[11] DavisB. H., VucicA.. The effect of retinol on Ito cell proliferation in vitro. Hepatology, 1988, 8(4): 788-793

[12] TakaseS., EnyamaK., TakadaA., et al.. Effects of vitamin A on collagen metabolism by cultured rat liver cells. Gastroenterol Jpn, 1992, 27(3): 354-363

[13] DavisB. H., RappU. R., DavidsonN. O.. Retinoic acid and transforming growth factor beta differentially inhibit platelet-derived-growth-factor-induced Ito-cell activation. Biochem J, 1991, 278(Pt1): 43-47

[14] Hisamori S, Tabata C, Kadokawa Y et al. All-trans-retinoic acid ameliorates carbon tetrachloride-induced liver fibrosis in mice through modulating cytokine production. Liver Int, 2008[Epub ahead of print]

[15] OkunoM., SatoT., KitamotoT., et al.. Increased 9,13-dicis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-β mediated fibrogenesis in vivo. J Hepatol, 1999, 30(6): 1073-1080

[16] OkunoM., MoriwakiH., ImaiS., et al.. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells. Hepatology, 1997, 26(4): 913-921

[17] ImaiS., OkunoM., MoriwakiH., et al.. 9,13-di-cis-Retinoic acid induces the production of tPA and activation of latent TGF-beta via RAR alpha in a human liver stellate cell line, LI90. FEBS Lett, 1997, 411(1): 102-106

[18] HellemansK., VerbuystP., QuartierE., et al.. Differential modulation of rat hepatic stellate phenotype by natural and synthetic retinoids. Hepatology, 2004, 39(1): 97-108

[19] DavisB. H., PrattB. M., MadriJ. A.. Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels. J Biol Chem, 1987, 262(21): 10 280-10 286

[20] SenooH., WakeK.. Suppression of experimental hepatic fibrosis by administration of vitamin A. Lab Invest, 1985, 52(2): 182-194

[21] SatoY., MuraseK., KatoJ., et al.. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol, 2008, 26(4): 431-442

[22] WangL., PotterJ. J., Rennie-TankersleyL., et al.. Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. Biochim Biophys Acta, 2007, 1772(1): 66-71

[23] OkunoM., MutoY., MoriwakiH., et al.. Inhibitory effect of acyclin retinoid (polyprenoic acid) on hepatic fibrosis in CCl₄-treated rats. Gastroenterol Jpn, 1990, 25(2): 223-229

[24] BlomhoffR.. Retinoids may increase fibrotic potential of TGF-beta: crosstalk between two multi-functional effectors. Hepatology, 1997, 26(4): 1067-1068

[25] OhataM., LinW., SatreM., et al.. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol, 1997, 272(3Pt1): G585-G596

[26] JiangH. Y., DanZ. L., WangH., et al.. Effect of ATRA on contents of liver retinoids, oxidative stress and hepatic injury in rat model of extrahepatic cholestasis. J Huazhong Univ Sci Technol (Med Sci), 2007, 27(5): 491-494

[27] Sentíes-GómezM. D., Gálevz-GastélumF. J., Meza-GarcíaE., et al.. Hepatic fibrosis: role of matrix metalloproteases and TGFbeta. Gac Med Mex, 2005, 141(4): 315-322

[28] ArthurM. J. P.. Collagenases and liver fibrosis. J Hepatol, 1995, 22(Suppl2): 43-48

[29] WatanabeT., NiiokaM., IshikawaA., et al.. Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. J Hepatol, 2001, 35(4): 465-473

[30] BenyonR. C., ArthurM. J. P.. Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis, 2001, 21(3): 373-384